SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $356,359 | -17.6% | 3,140 | 0.0% | 0.10% | -19.8% |
Q1 2023 | $432,485 | +20.3% | 3,140 | +9.0% | 0.13% | +8.3% |
Q4 2022 | $359,539 | -68.2% | 2,880 | -64.2% | 0.12% | -70.7% |
Q3 2020 | $1,130,000 | -11.8% | 8,050 | +0.8% | 0.41% | -20.4% |
Q2 2020 | $1,281,000 | +63.8% | 7,990 | 0.0% | 0.52% | +30.4% |
Q1 2020 | $782,000 | -47.4% | 7,990 | -30.6% | 0.40% | -30.1% |
Q4 2019 | $1,486,000 | +48.2% | 11,518 | -13.5% | 0.57% | +34.2% |
Q3 2019 | $1,003,000 | -37.6% | 13,320 | +25.9% | 0.42% | -38.5% |
Q2 2019 | $1,608,000 | +68.7% | 10,580 | +32.3% | 0.69% | +63.7% |
Q1 2019 | $953,000 | +0.8% | 7,998 | -7.6% | 0.42% | -10.2% |
Q4 2018 | $945,000 | -31.8% | 8,658 | +1.0% | 0.47% | -15.9% |
Q3 2018 | $1,385,000 | +24.4% | 8,575 | +3.9% | 0.56% | +17.0% |
Q2 2018 | $1,113,000 | +396.9% | 8,255 | +172.4% | 0.48% | +402.1% |
Q1 2018 | $224,000 | -33.1% | 3,030 | -82.7% | 0.10% | -49.5% |
Q2 2016 | $335,000 | -2.3% | 17,550 | 0.0% | 0.19% | -3.6% |
Q1 2016 | $343,000 | – | 17,550 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |